DETECTION OF OPRD, MEXA AND MEXB GENES IN THE CLINICAL ISOLATES OF PSEUDOMONAS AERUGINOSA AND THEIR ANTIMICROBIAL SUSPICIBILITY PATTERNS
Ключевые слова:
Pseudomonas aeruginosa, Porins, Carbapenems, Over-expressioАннотация
Background: Pseudomonas aeruginosa is an important opportunistic pathogen associated with hospital acquired infection, particularly in wound and respiratory specimens. Objective: This is study aimed to detect the presence of oprD, mexA And mexB genes in clinical isolates of Pseudomonas aeruginosa and to describe their antimicrobial resistance patterns. Material and methods: One hundred clinical specimens from wound and respiratory infections were collected and processed using standard bacteriological methods. Presumptive P. aeruginosa isolates were identified phenotypically and then confirmed by PCR amplification of the 16S rRNA gene. The resistance -associated genes mexA, mexB , and oprD were screened by PCR to asses the molecular profile of the confirmed isolates. Results: out of 100 samples , 20 isolates were confirmed as P. aeruginosa giving an isolation rate of 20% . All confirmed isolates were positive for 16S rRNA , mexA, mexB , and oprD . The universal detection of these genes indicates successful molecular confirmation and suggests the presence of efflux pump -mediated resistance and outer membrane permeability -related resistance mechanisms . Conclusion: The study confirmed the presence of 16S rRNA , mexA , mexB and oprD genes in the clinical isolates of Pseudomonas arginosa Obtained from wound and respiratory samples. The isolates is also showed varying antimicrobial susceptibility patterns. However, PCR detection alone does not demonstrate gene expression or functional resistance mechanism. Therefore, the result should be interpreted as molecular detection of resistance-associated genes, not as direct proof of carbapenem resistance or multidrug resistance. Further studies using sequencing, gene expression analysis, and function assays are needed to clarify the role of these genes in antimicrobial resistance.
Библиографические ссылки
Wang M, Zhang Y, Pei F, Liu Y, Zheng Y. Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa. BMC microbiology. 2025 Apr 16;25(1):218.
Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, Davis SK. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nature communications. 2021 Feb 19;12(1):1162.
Soulaimani B. Comprehensive review of the combined antimicrobial activity of essential oil mixtures and synergism with conventional antimicrobials. Natural Product Communications. 2025 Mar;20(3):1934578X251328241.
Kürkçü MF, Fatsa T, Tanriverdi ES, Karakuş H, Hoşbul T, Otlu B. Investigation of resistance nodulation division (RND) efflux pump and OPRD expression levels in antibiotic resistance of clinical Pseudomonas aeruginosa isolates. Mikrobiyoloji Bulteni. 2024 Oct 1;58(4):393-407.
Kao CY, Chen SS, Hung KH, Wu HM, Hsueh PR, Yan JJ, Wu JJ. Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan. BMC microbiology. 2016 Jun 13;16(1):107.
Matsumoto Y, Yamasaki S, Hayama K, Iino R, Noji H, Yamaguchi A, Nishino K. Changes in the expression of mexB, mexY, and oprD in clinical Pseudomonas aeruginosa isolates. Proceedings of the Japan Academy, Series B. 2024 Jan 11;100(1):57-67.
Wang M, Zhang Y, Pei F, Liu Y, Zheng Y. Loss of OprD function is sufficient for carbapenem-resistance-only but insufficient for multidrug resistance in Pseudomonas aeruginosa. BMC microbiology. 2025 Apr 16;25(1):218.
Wheatley R, Diaz Caballero J, Kapel N, De Winter FH, Jangir P, Quinn A, del Barrio-Tofino E, Lopez-Causape C, Hedge J, Torrens G, Van der Schalk T. Rapid evolution and host immunity drive the rise and fall of carbapenem resistance during an acute Pseudomonas aeruginosa infection. Nature Communications. 2021 Apr 28;12(1):2460.
Al-Fanharawi AH, Al-Shamarti MJ. The outer membrane protein D gene mutations and carbapenem resistance in Pseudomonas Aeruginosa isolated from burns infection in Al-Najaf/Iraq. International Journal of Health Sciences.;6(S4):12425-38.
Saidmurad MA, AL-Jubori SS. Sequencing analysis of efflux pump and porin genes among Pseudomonas aeruginosa isolated from different sources. Reviews and Research in Medical Microbiology. 2025 Jul 1;36(3):134-46.
Bhandari S, Adhikari S, Karki D, Chand AB, Sapkota S, Dhungel B, Banjara MR, Joshi P, Lekhak B, Rijal KR. Antibiotic resistance, biofilm formation and detection of mexA/mexB efflux-pump genes among clinical isolates of Pseudomonas aeruginosa in a Tertiary Care Hospital, Nepal. Frontiers in Tropical Diseases. 2022 Feb 17;2:810863.
Li H, Luo YF, Williams BJ, Blackwell TS, Xie CM. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. International Journal of Medical Microbiology. 2012 Mar 1;302(2):63-8.
Cabrera R, Fernández-Barat L, Vázquez N, Alcaraz-Serrano V, Bueno-Freire L, Amaro R, López-Aladid R, Oscanoa P, Muñoz L, Vila J, Torres A. Resistance mechanisms and molecular epidemiology of Pseudomonas aeruginosa strains from patients with bronchiectasis. Journal of Antimicrobial Chemotherapy. 2022 Jun 1;77(6):1600-10.
M. Beig, M. Taheri, and M. R. Arabestani, “Expression of MexAB-OprM efflux pump and OprD porin in carbapenemase producing Pseudomonas aeruginosa clinical isolates,” Gene Reports, vol. 20, Art. no. 100744, Sep. 2020, doi: 10.1016/j.genrep.2020.100744.
W. Wu, J. Huang, and Z. Xu, “Antibiotic influx and efflux in Pseudomonas aeruginosa: Regulation and therapeutic implications,” Microbial Biotechnology, vol. 17, no. 5, Art. no. e14487, May 2024, doi: 10.1111/1751-7915.14487.
Загрузки
Опубликован
Как цитировать
Выпуск
Раздел
Лицензия
Copyright (c) 2026 Mohammed Mahjoob Aljuboori , Ghufran Mudher Khalaf , Ahmed Daham Hammadi

Это произведение доступно по лицензии Creative Commons «Attribution» («Атрибуция») 4.0 Всемирная.
CC BY
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use. CC BY includes the following elements:
BY: credit must be given to the creator.